The Race to Prepare for Medicare’s New Drug Pricing Powers

The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.


Guests:

Alice Valder Curran, JD, Partner, Hogan Lovells

Sean Dickson, JD, MPH, Director of Health Policy, West Health Policy Center

Amber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human Services

Mark Newsom, Founder and Principal, Health Evaluations


Learn more and read a full transcript on our website.


Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.


Support this type of journalism today, with a gift.


Follow us on Twitter. 


Hosted on Acast. See acast.com/privacy for more information.

More from Tradeoffs

  1. 26:34How Do You Help Patients Who Show Up in the ER 100 Times a Year?Apr 25, 2024
  2. 20:35An Insurance Company Bought This Doctor’s Practice. She’s Worried About Her PatientsApr 18, 2024
  3. 20:4992,000 Transgender People Took This Survey. Here’s What We LearnedApr 11, 2024
  4. 23:32Girls Are in a Mental Health Crisis. What Can Schools Do?Apr 04, 2024
  5. 19:41Surprise! Plans To Resolve High Medical Bills Are Still a MessMar 28, 2024
  6. 31:17One Doctor’s Quest to Improve Health Care for People with DisabilitiesMar 21, 2024
  7. 22:11Can Washington Make Medicare and Medicaid Work Better Together?Mar 14, 2024
  8. 24:29How Patient Privacy Could Hurt AIMar 07, 2024
  9. 18:02How Pushing Hospitals to Give Away More Free Care Could BackfireFeb 29, 2024
  10. 23:28‘She Didn’t Want to Die. But She Didn’t Want to Suffer.’Feb 22, 2024